SI1635843T1 - Terapija, ki vsebuje dienogest, za hormonsko nadomestitev in depresijo - Google Patents
Terapija, ki vsebuje dienogest, za hormonsko nadomestitev in depresijoInfo
- Publication number
- SI1635843T1 SI1635843T1 SI200431086T SI200431086T SI1635843T1 SI 1635843 T1 SI1635843 T1 SI 1635843T1 SI 200431086 T SI200431086 T SI 200431086T SI 200431086 T SI200431086 T SI 200431086T SI 1635843 T1 SI1635843 T1 SI 1635843T1
- Authority
- SI
- Slovenia
- Prior art keywords
- dienogest
- depression
- therapy
- hormone replacement
- hormone
- Prior art date
Links
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 title abstract 2
- 229960003309 dienogest Drugs 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Surface Treatment Of Glass Fibres Or Filaments (AREA)
- Lubricants (AREA)
- Injection Moulding Of Plastics Or The Like (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48215403P | 2003-06-25 | 2003-06-25 | |
| US48843903P | 2003-07-21 | 2003-07-21 | |
| PCT/IB2004/002535 WO2004112797A1 (en) | 2003-06-25 | 2004-06-25 | Hormone replacement- and depression therapy comprising dienogest |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1635843T1 true SI1635843T1 (sl) | 2009-06-30 |
Family
ID=33544504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431086T SI1635843T1 (sl) | 2003-06-25 | 2004-06-25 | Terapija, ki vsebuje dienogest, za hormonsko nadomestitev in depresijo |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20050032758A1 (sl) |
| EP (1) | EP1635843B1 (sl) |
| JP (1) | JP2007528358A (sl) |
| AT (1) | ATE419855T1 (sl) |
| DE (1) | DE602004018921D1 (sl) |
| DK (1) | DK1635843T3 (sl) |
| ES (1) | ES2320662T3 (sl) |
| PL (1) | PL1635843T3 (sl) |
| PT (1) | PT1635843E (sl) |
| SI (1) | SI1635843T1 (sl) |
| WO (1) | WO2004112797A1 (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| CA2566811A1 (en) * | 2004-05-26 | 2005-12-15 | Wyeth | Compositions and methods for treatment of premenstrual dysphoric disorder |
| EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
| US20100155594A1 (en) * | 2008-12-23 | 2010-06-24 | Goldman Mildred M | Mass spectrometry assay for estrogenic compounds |
| BE1027858B1 (fr) * | 2019-12-13 | 2021-07-14 | Georges Debled | Composition pharmaceutique pour la contraception chez la femme |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US165209A (en) * | 1875-07-06 | Improvement in automatic shut-off attachments for water-closets | ||
| US198671A (en) * | 1877-12-25 | Improvement in apparatus for recovering alkali from waste solutions | ||
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
| JP2000515890A (ja) * | 1996-07-26 | 2000-11-28 | アメリカン・ホーム・プロダクツ・コーポレイション | プロゲスチンとエストロゲンとの混合剤からなる一相性避妊法およびキット |
| US6306914B1 (en) * | 1997-10-21 | 2001-10-23 | Columbia Laboratories, Inc. | Progestin therapy for maintaining amenorrhea |
| CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
| WO2003041718A1 (en) * | 2001-11-15 | 2003-05-22 | Pantarhei Bioscience B.V. | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| WO2003082299A1 (en) * | 2002-04-03 | 2003-10-09 | Jencap Research Ltd. | Improved hormone replacement therapy |
-
2004
- 2004-06-25 PT PT04744181T patent/PT1635843E/pt unknown
- 2004-06-25 AT AT04744181T patent/ATE419855T1/de active
- 2004-06-25 DE DE602004018921T patent/DE602004018921D1/de not_active Expired - Lifetime
- 2004-06-25 ES ES04744181T patent/ES2320662T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/875,521 patent/US20050032758A1/en not_active Abandoned
- 2004-06-25 WO PCT/IB2004/002535 patent/WO2004112797A1/en active Application Filing
- 2004-06-25 JP JP2006516611A patent/JP2007528358A/ja active Pending
- 2004-06-25 SI SI200431086T patent/SI1635843T1/sl unknown
- 2004-06-25 EP EP04744181A patent/EP1635843B1/en not_active Expired - Lifetime
- 2004-06-25 DK DK04744181T patent/DK1635843T3/da active
- 2004-06-25 PL PL04744181T patent/PL1635843T3/pl unknown
-
2012
- 2012-03-02 US US13/411,131 patent/US20120225853A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL1635843T3 (pl) | 2009-06-30 |
| ATE419855T1 (de) | 2009-01-15 |
| WO2004112797A1 (en) | 2004-12-29 |
| DK1635843T3 (da) | 2009-05-04 |
| DE602004018921D1 (de) | 2009-02-26 |
| EP1635843B1 (en) | 2009-01-07 |
| US20120225853A1 (en) | 2012-09-06 |
| EP1635843A1 (en) | 2006-03-22 |
| PT1635843E (pt) | 2009-04-07 |
| ES2320662T3 (es) | 2009-05-27 |
| US20050032758A1 (en) | 2005-02-10 |
| JP2007528358A (ja) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002092102A3 (en) | Treatment of conditions relating to hormone deficiencies by administration of progestins | |
| TW200716137A (en) | Tanaproget compositions containing ethinyl estradiol | |
| NZ594476A (en) | Steroid sparing agents and methods of using same | |
| PL2131847T3 (pl) | Lek zawierający przynajmniej jeden gestagen | |
| AU2003213075A1 (en) | Subretinal implantation device and surgical cannulas for use therewith | |
| AU2002342074A1 (en) | Medical device for delivering patches | |
| NZ524104A (en) | Exemestane as chemopreventing agent | |
| IL169583A0 (en) | Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis | |
| WO2003102012A3 (en) | New etonogestrel esters | |
| MY146794A (en) | Use of an alpha-2-delta ligand for the treatment of luts | |
| PT1526856E (pt) | Composição farmacêutica que compreende derivados do estretol para ser utilizada no tratamento do cancro | |
| MY137620A (en) | Therapeutic treatment | |
| PL1635843T3 (pl) | Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest | |
| RS90504A (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| MXPA04005417A (es) | Uso de antagonista de h1 y un esteroide seguro para el tratamiento de la rinitis. | |
| MXPA05010871A (es) | Metodos para administrar estrogenos y progestinas. | |
| MX2009000950A (es) | Uso del antagonista del receptor de glucocorticoide para el tratamiento de padecimientos infecciosos. | |
| WO2002020000A3 (en) | Combined estrogen blockade of the breast with exemestane and raloxifene | |
| AU2003285485A1 (en) | 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION | |
| MXPA02002043A (es) | Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo. | |
| IS7204A (is) | Notkun á (11ß, 17ß)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón við meðhöndlun á stórvægilegri geðlægðartruflun | |
| IL165779A0 (en) | Steroid conjugate, preparation thereof and the usethereof | |
| AU2002368326A1 (en) | Hormone replacement therapy with drospirenone | |
| WO2003039455A3 (en) | Methods of treating endometreosis | |
| WO2006042561A3 (en) | Intrauterine contraceptive system with copper and progesterone |